Timothy J. Mann
Liverpool, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The role of molecular profiling for castration-resistant prostate cancer treatment and therapy development.
Journal: Frontiers in cell and developmental biology
Published: May 29, 2026
The innate immune mediator group IIA secreted phospholipase A2 modulates lipid droplet formation in prostate cancer cells.
Journal: Frontiers in cell and developmental biology
Published: December 23, 2025
Chemotherapeutic Potential of Fluorouracil-Platinum (IV) Prodrugs Against Cisplatin-Resistant Colorectal Cancer Cells.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany)
Published: November 13, 2025
Targeting secreted PLA2 interactions with EGFR and vimentin to arrest prostate tumour growth.
Journal: Cell death & disease
Published: February 07, 2025
Chemotherapeutic Potential of Chlorambucil-Platinum(IV) Prodrugs against Cisplatin-Resistant Colorectal Cancer Cells.
Journal: International journal of molecular sciences
Published: June 12, 2024
Human Group IIA Phospholipase A2-Three Decades on from Its Discovery.
Journal: Molecules (Basel, Switzerland)
Published: November 08, 2021
Structural and Functional Aspects of Targeting the Secreted Human Group IIA Phospholipase A2.
Journal: Molecules (Basel, Switzerland)
Published: August 17, 2020
The cost-effectiveness of unilateral cochlear implants in UK adults.
Journal: The European journal of health economics : HEPAC : health economics in prevention and care
Published: April 08, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026